Regencell Bioscience Holdings Limited (RGC) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 4.9M | 6.59M | 8.11M | 9.83M | 11.62M | 14.19M | 16.44M | 19.01M | 66.85K | 305.96K | 386.98K | 243.31K |
| Cash & Short-Term Investments | 4.9M | 0 | 7.96M | 4.8M | 11.56M | 0 | 16.42M | 0 | 59.41K | 305.96K | 386.98K | 243.31K |
| Cash Only | 2.42M | 0 | 2.96M | 4.8M | 1.56M | 0 | 6.42M | 0 | 59.41K | 305.96K | 386.98K | -243.31K |
| Short-Term Investments | 2.48M | 0 | 5M | 0 | 10M | 0 | 10M | 0 | 0 | 0 | 0 | 486.61K |
| Accounts Receivable | 0 | 0 | 152.78K | 0 | 56.55K | 0 | 0 | 0 | 7.44K | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | -56.55K | 0 | -27.6K | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.8K | 6.59M | 0 | 5.03M | 0 | 14.19M | 0 | 19.01M | -7.44K | 0 | 0 | 0 |
| Total Non-Current Assets | 852.77K | 892.74K | 324.2K | 642.42K | 1M | 1.36M | 1.57M | 2.05M | 273.29K | 294.42K | 127.04K | -243.31K |
| Property, Plant & Equipment | 759.82K | 0 | 226.51K | 0 | 891.91K | 0 | 1.46M | 0 | 81.86K | 110.26K | 108.32K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | -1603.95x | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 92.95K | 892.74K | 97.68K | 642.42K | 108.5K | 1.36M | 114.3K | 2.05M | 191.42K | 184.16K | 18.72K | -243.31K |
| Total Assets | 5.76M | 7.48M | 8.44M | 10.48M | 12.62M | 15.55M | 18.02M | 21.06M | 340.13K | 600.37K | 514.02K | 0 |
| Asset Turnover | - | - | - | - | - | - | -119.84x | - | - | - | - | - |
| Asset Growth % | -31.79% | -28.6% | -33.15% | -32.63% | -29.95% | -26.18% | 5197.59% | 3408.3% | -33.83% | - | - | - |
| Total Current Liabilities | 663.67K | 0 | 193.58K | 0 | 606.91K | 0 | 577.76K | 1.36K | 4.34M | 3.59M | 3.16M | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 312.78K | 0 | 0 | 0 | 0 | 0 | 0 | 1.36K | 3.68M | 3.54M | 3.07M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 350.89K | 0 | 0 | 0 | 0 | 0 | 0 | -1.36K | 0 | 0 | 0 | 0 |
| Current Ratio | 7.39x | - | 41.92x | - | 19.15x | - | 28.46x | 13939.67x | 0.02x | 0.09x | 0.12x | - |
| Quick Ratio | 7.39x | - | 41.92x | - | 19.24x | - | 28.51x | 13939.67x | 0.02x | 0.09x | 0.12x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 231.63K | 763.84K | 25.93K | 312.55K | 25.41K | 873.79K | 360.27K | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 231.63K | 0 | 25.93K | 0 | 25.41K | 0 | 360.27K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 763.84K | 0 | 312.55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 895.31K | 763.84K | 219.51K | 312.55K | 632.32K | 873.79K | 938.03K | 1.36M | 4.34M | 3.59M | 3.16M | 0 |
| Total Debt | 544.41K | 0 | 85.74K | 0 | 463.67K | 0 | 771.25K | 1.36K | 3.68M | 3.54M | 3.07M | 0 |
| Net Debt | -1.87M | 0 | -2.88M | -4.8M | -1.1M | 0 | -5.65M | 1.36K | 3.62M | 3.24M | 2.68M | 243.31K |
| Debt / Equity | 0.11x | - | 0.01x | - | 0.04x | - | 0.05x | 0.00x | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 4.86M | 6.72M | 8.22M | 10.16M | 11.99M | 14.66M | 17.08M | 19.7M | -4M | -2.98M | -2.65M | -1.84M |
| Equity Growth % | -40.86% | -33.92% | -31.45% | -30.67% | -29.81% | -25.59% | 527.27% | 759.99% | -50.8% | -62.34% | - | - |
| Book Value per Share | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | -0.01 | -0.01 | -0.01 | -0.00 |
| Total Shareholders' Equity | 4.86M | 6.72M | 8.22M | 10.16M | 12.03M | 14.66M | 17.07M | 19.7M | -4M | -2.98M | -2.65M | -1.84M |
| Common Stock | 4.95K | 6.72M | 130 | 10.16M | 130 | 14.67K | 130 | 19.7M | 100 | 100 | 100 | 0 |
| Retained Earnings | -25.2M | 0 | -21.62M | 0 | -17.32M | 0 | -11.44M | 0 | -4M | -2.99M | -2.65M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -64.79K | 0 | -45.77K | 0 | -86.66K | 0 | 0 | 0 | 0 | -22.85K | -9.52K | -1.84M |
| Minority Interest | 0 | 0 | 0 | 0 | -40.9K | 0 | 15.39K | 0 | 0 | 0 | 0 | 0 |